-
Next-Generation Point-of-Care Molecular Diagnostics Technologies: Transforming the Healthcare Industry in 2025
30 Jan 2025 18:02 GMT
… cancer and genetic diseases, customized molecular diagnostics for various applications, … Inc., Sysmex Corporation, Illumina Inc., Myriad Genetics Inc.
What Are The Key … .com/report/molecular-diagnostics-devices-and-equipment-global …
-
Cancer Genetic Testing Market Size to Worth USD 17.98 Billion by 2033 | Straits Research
30 Jan 2025 15:22 GMT
… ;chromosome analysis, biochemical testing, molecular testing, DNA sequencing, and others … somatic cancer.
February 2024- Myriad Genetics acquired Precise Tumor, Precise Liquid … ;Chromosome Analysis
Biochemical Testing
Molecular Testing
DNA Sequencing
By …
-
Tissue Diagnostics Technologies and Global Markets Revenue Data from 2022 to 2023, Estimates for 2024, Forecasts for 2025 and Projected CAGRs through 2029 - ResearchAndMarkets.com
30 Jan 2025 13:52 GMT
… ;E) and immunohistochemistry (IHC); molecular pathology, which includes in situ … , by Segment
Histopathology Market
Molecular Pathology Market
Microbiology Testing Market … Illumina
Koninklijke Philips
Merck KGaA
Myriad Genetics
Qiagen
Thermo Fisher Scientific
…
-
MD Anderson and Myriad Genetics Form Strategic Alliance to Evaluate Clinical Utility of Myriad's Molecular Residual Disease Assay
07 Jan 2025 16:10 GMT
… and development of Myriad’s molecular residual disease (MRD) assay.
… longstanding oncology diagnostic experience of Myriad Genetics and the clinical and … MD Anderson Newsroom.
-30-
About Myriad Genetics
Myriad Genetics is a leading genetic testing …
-
Myriad Genetics and MD Anderson partner to evaluate molecular residual disease assay
07 Jan 2025 14:49 GMT
… development of Myriad's molecular residual disease (MRD) assay.
This … longstanding oncology diagnostic experience of Myriad Genetics and the clinical and translational … the agreement, MD Anderson and Myriad Genetics will collaborate to design both …
-
MD Anderson and Myriad Genetics Join Forces to Assess Clinical Utility of Myriad’s Molecular Residual Disease Assay
07 Jan 2025 13:55 GMT
… the chief scientific officer at Myriad Genetics, expressed excitement regarding the … Molecular Residual Disease Assay
Article Title: MD Anderson and Myriad Genetics … MRD testing, cancer diagnostics, Myriad Genetics, MD Anderson Cancer Center, personalized …
-
MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay
07 Jan 2025 13:00 GMT
… and development of Myriad’s molecular residual disease (MRD) assay. … longstanding oncology diagnostic experience of Myriad Genetics and the clinical and … and renal cell carcinoma. About Myriad Genetics
Myriad Genetics is a leading genetic testing …
-
Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report
06 Jan 2025 13:00 GMT
… do at Myriad Genetics,” said Paul J. Diaz, President and CEO, Myriad Genetics. “In … to develop new technologies like molecular residual disease (MRD) assay and … read the report here. About Myriad Genetics
Myriad Genetics is a leading genetic testing …
-
Molecular Diagnostics Market Size, Share & Business Opportunities forecast by 2031 | F. Hoffmann-La Roche Ltd, Illumina
15 Jan 2025 07:42 GMT
… .
⏩ Key Highlights of our Molecular Diagnostics Market Research Report:
» … Regional analysis, highlighting variations in Molecular Diagnostics usage and competition.
» … Inc.
• Qiagen N.V.
• Myriad Genetics
• Becton
• Dickinson and Company
• …
-
Molecular Diagnostics for Cancer Market Report 2025 with Executive and Consultant Guides, & Profiles of 140+ Companies - ResearchAndMarkets.com
09 Jan 2025 14:28 GMT
… serve a global patient base.
Molecular Diagnostics for Cancer. Markets … and Gene Therapy
5 Molecular Diagnostics Recent Developments
5. … Cancer
5.8 Qiagen and Myriad Genetics Partner to Develop Cancer … Oncology
6.37 Caris Molecular Diagnostics
6.38 Castle …